Public Release: 28-Jul-2015
American Society for Microbiology
WASHINGTON, DC – July 28, 2015 – Microbes contributing to cystic fibrosis (CF) are able to survive in saliva and mucus that is chemically heterogeneous, including significant portions that are largely devoid of oxygen, according to a study published this week in mBio®, the online open-access journal of the American Society for Microbiology.
The study, which evaluated sputum samples from 22 pediatric CF patients, found that the microbiologic environment can differ between patients, and even within the same patient at different points in time. Researchers also noted that a number of samples contained the gas hydrogen sulfide, a form of sulfur that reacts with and removes oxygen from the environment. Patients who had detectable hydrogen sulfide in their sputum tended to have less severe disease symptoms.
The findings shed a light on the conditions under which CF microbes can survive, said senior study coauthor Dianne K. Newman, PhD, professor of biology and geobiology at the California Institute of Technology, Pasadena, California.
“The diversity and adaptation of disease-causing microorganisms within the CF lung environment, in part, is what renders CF infections so difficult to eradicate,” Newman said. “Few studies have attempted to characterize the chemistry of mucus collecting in CF airways, yet such measurements are essential if we are to understand how microorganisms survive in the lung and impact the microenvironment.”
For the study, researchers employed tools called microsensors, normally used for environmental research, to measure high-resolution profiles of the oxygen and sulfide levels of 48 fresh sputum samples from 22 pediatric CF patients seen at Children’s Hospital Los Angeles. They also looked at the samples’ chemistry and their oxidation-reduction potential, a measurement of an environment’s tendency to give or receive electrons. They found that the samples had just a very thin layer of oxygen at the surface, but the bulk of the samples were depleted of oxygen.
Of the samples profiled, 32 also were cultured for dominant CF disease-causing microorganisms by the hospital’s clinical microbiology laboratory. Thirteen samples harbored Pseudonomas aeruginosa, 12 had Staphylococus aureus, five were positive for both and two had neither.
“We found oxygen only at the very narrow interface between the air and samples,” said senior study coauthor Wiebke Ziebis, PhD, associate professor of biological sciences at the University of Southern California in Los Angeles. “It’s not only a stratified environment, with different microbial communities at different depths of the sputum, but also temporarily dynamic – there were differences not only between patients but also at different time points for the same patients.”
Cystic fibrosis, which affects about 70,000 individuals worldwide, is a genetic disorder that affects the cells that produce mucus, sweat and digestive juices. These secretions are normally thin, but because of a defective gene, in CF they become thick and sticky. People living with CF are susceptible to chronic lung infection because of their inability to clear thickened mucus from the airways.
Further study is needed to determine whether particular metabolic fingerprints correlate with disease progression and, if so, which treatments would be most effective under these conditions, the authors said. “A greater diversity of metabolic survival strategies need to be considered and understood, including ones that operate solely under no-oxygen conditions, because that represents an important reservoir within this habitat,” Newman said.
The study was supported by the National Institutes of Health and the Howard Hughes Medical Institute.
mBio® is an open access online journal published by the American Society for Microbiology to make microbiology research broadly accessible. The focus of the journal is on rapid publication of cutting-edge research spanning the entire spectrum of microbiology and related fields. It can be found online at http://mbio.asm.org.
The American Society for Microbiology is the largest single life science society, composed of over 39,000 scientists and health professionals. ASM’s mission is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide.
Categories: Missed - Medical Breakthroughs